RxSight (RXST) Amortizatization of Intangibles (2020 - 2026)
RxSight's (RXST) quarterly Amortizatization of Intangibles came in at $1.9 million in Q1 2026, down 23.1% YoY from $2.4 million in Q1 2025, and up 1.2% on a QoQ basis from $1.8 million in Q4 2025.
RxSight (RXST) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
RxSight (RXST) has 7 years of Amortizatization of Intangibles data on file, last reported at $1.9 million in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 23.1% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 million (down 19.46% YoY) and the FY2025 annual result came in at $8.5 million, down 5.12% from the prior year.
- Amortizatization of Intangibles rose to $1.9 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.8 million in Q3 2024 to a low of $47000.0 in Q1 2022.
- A 5-year average of $1.6 million and a median of $1.7 million in 2023 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles surged 9675.0% — and 2025, when it sank 30.29%.
- Tracing RXST's Amortizatization of Intangibles over 5 years: stood at $783000.0 in 2022, then jumped by 101.4% to $1.6 million in 2023, then surged by 66.65% to $2.6 million in 2024, then tumbled by 30.29% to $1.8 million in 2025, then advanced by 1.2% to $1.9 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $1.9 million (Q1 2026), $1.8 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | RxSight | 259.94 Mn | -144.31 Mn | - | 1.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Mn |
| Jun 30, 2026 | 1.75 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 2.13 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Mar 31, 2025 | 2.41 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Dec 31, 2024 | 2.63 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |